A Study to Evaluate Upadacitinib in Combination With Topical Corticosteroids in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis
Clinical trial NCT03568318 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03568318
- Sponsor
- AbbVie
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-09
- Primary completion
- 2021-02-16
- Enrollment
- 1533
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.